EcoDrugPlus

Ensembl ID : WBGene00226145
Gene Symbol: WBGENE00226145
4 External references
111 Possible Orthologues:

Ensembl ID : WBGene00226152
Gene Symbol: WBGENE00226152
3 External references
224 Possible Orthologues:

Ensembl ID : WBGene00226185
Gene Symbol: WBGENE00226185
3 External references
196 Possible Orthologues:

Ensembl ID : WBGene00226187
Gene Symbol: WBGENE00226187
4 External references
77 Possible Orthologues:

Ensembl ID : WBGene00226199
Gene Symbol: WBGENE00226199
6 External references
202 Possible Orthologues:

Ensembl ID : WBGene00226213
Gene Symbol: WBGENE00226213
4 External references
125 Possible Orthologues:

Ensembl ID : WBGene00226268
Gene Symbol: WBGENE00226268
3 External references
60 Possible Orthologues:

Ensembl ID : WBGene00226276
Gene Symbol: WBGENE00226276
3 External references
933 Possible Orthologues:

Ensembl ID : WBGene00226320
Gene Symbol: WBGENE00226320
4 External references
329 Possible Orthologues:

Ensembl ID : WBGene00226330
Gene Symbol: WBGENE00226330
6 External references
41 Possible Orthologues:

Ensembl ID : WBGene00226333
Gene Symbol: WBGENE00226333
6 External references
177 Possible Orthologues:

Ensembl ID : WBGene00220320
Gene Symbol: WBGENE00220320
3 External references
1193 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).